Comment on: Andexanet alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

被引:0
|
作者
Lier, H. [1 ]
Grottke, O. [2 ]
机构
[1] Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, Cologne, Germany
[2] Univ Klinikum RWTH Aachen, Klin Anasthesiol, Expt Hamostaseol, Pauwelsstr 30, D-52074 Aachen, Germany
来源
ANAESTHESIST | 2016年 / 65卷 / 12期
关键词
REVERSAL;
D O I
10.1007/s00101-016-0240-x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:940 / 941
页数:2
相关论文
共 50 条
  • [41] Andexanet Alfa Corrects the Interference of Direct Factor Xa Inhibitors on Lupus Anticoagulant Testing
    Baker, Ross I.
    Gilmore, Grace
    McGregor, Scott
    BLOOD, 2016, 128 (22)
  • [42] REVERSAL OF FACTOR XA INHIBITORS-INDUCED ANTICOAGULATION IN HEALTHY SUBJECTS BY ANDEXANET ALFA
    Crowther, Mark
    Lu, Genmin
    Conley, Pamela
    Leeds, Janet
    Castillo, Janice
    Levy, Gallia
    Connolly, Stuart
    Curnutte, John
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [43] The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis
    Siegal, Deborah
    Beyer-Westendorf, Jan
    Yue, Patrick
    Souza, Sonia
    Nakamya, Juliet
    Connolly, Stuart J.
    Crowther, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S332 - S333
  • [44] A meta-analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor-related major bleeding
    Jaspers, Tessa
    Shudofsky, Kimberly
    Huisman, Menno V.
    Meijer, Karina
    Khorsand, Nakisa
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (04)
  • [45] Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa
    Bourdin, Matthieu
    Perrotin, Delphine
    Mathieu, Olivier
    Herve, Tristan
    Depasse, Francois
    Lu, Genmin
    Conley, Pamela B.
    Contant, Genevieve
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : 795 - 801
  • [46] Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study
    Singer, Adam J.
    Concha, Mauricio
    Williams, James
    Brown, Caitlin S.
    Fernandes, Rafael
    Thode, Henry C., Jr.
    Kirchman, Marylin
    Rabinstein, Alejandro A.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2023, 24 (05) : 939 - 949
  • [47] Efficacy and safety of andexanet alfa for factor Xa inhibitor-associated intracranial haemorrhage
    Tsivgoulis, Georgios
    Katsanos, Aristeidis H.
    Romoli, Michele
    Sarraj, Amrou
    Krogias, Christos
    Karapanayiotides, Theodoros
    Theodorou, Aikaterini
    Stefanou, Maria Ioanna
    Molina, Carlos A.
    Themistocleous, Marios
    Steiner, Thorsten
    Shoamanesh, Ashkan
    Palaiodimou, Lina
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2025,
  • [48] Three cases of neutralization of factor Xa inhibitors with andexanet alfa under rotational thromboelastography monitoring
    Yagi, Takeshi
    Kawano, Reina
    Tomokage, Takuto
    Ayata, Ryo
    Koga, Yasutaka
    Kaneda, Kotaro
    Fujita, Motoki
    Yamanaka, Nanami
    Mori, Naomasa
    Tsuruta, Ryosuke
    ACUTE MEDICINE & SURGERY, 2024, 11 (01):
  • [49] Reversal of Heparin-Induced Anticoagulation By Andexanet Alfa, a Universal Antidote for Factor Xa Inhibitors
    Lu, Genmin
    Lin, Joyce
    Curnutte, John T.
    Conley, Pamela B.
    BLOOD, 2015, 126 (23)
  • [50] Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent
    Powell, Jason
    Taylor, James
    Garland, Scott G.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (09) : 940 - 946